Find information on thousands of medical conditions and prescription drugs.

Ventolin

Ventolin means at least these things:

  • Salbutamol-based asthma-medicine.
  • Song by Aphex Twin. It is inspired by aforementioned medicine.
Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
Hydrocodone
Vagifem
Valaciclovir
Valcyte
Valganciclovir
Valine
Valium
Valnoctamide
Valproate semisodium
Valproic acid
Valpromide
Valrelease
Valsartan
Valstar
Valtrex
Vancenase
Vanceril
Vancomycin
Vaniqa
Vanticon
Vecuronium bromide
Velcade
Velivet
Venlafaxine
Ventolin
Vepesid
Verapamil
Verelan
Vermox
Versed
Vfend
Viadur
Viagra
Vicoprofen
Vidarabine
Vidaza
Videx
Vigabatrin
Viloxazine
Vinblastine
Vincristine
Vinorelbine
Viomycin
Vioxx
Viracept
Viread
Visine
Vistide
Visudyne
Vitaped
Vitrase
Vivelle
Volmax
Voltaren
Voriconazole
Vosol
W
X
Y
Z

Read more at Wikipedia.org


[List your site here Free!]


FDA Approves New Inhaler Without CFCs - Ventolin HFA - Brief Article
From FDA Consumer, 7/1/01

The FDA has approved Ventolin HFA (albuterol sulfate HFA), a new version of the Ventolin metered-dose inhaler (MDI) for asthma and other obstructive lung diseases.

Unlike the currently marketed version of Ventolin, this new inhaler uses an alternative propellant called HFA (hydrofluoroalkane) to propel medication rather than ohlorofluorocarbons (CFCs). GlaxoSmithKline, Research Triangle Park, N.C., manufactures both Ventolin products.

The approval of Ventolin HFA means that there are now two albuterol HFA MDIs approved for use in the United States. The first, Proventil HFA, marketed by Key Pharmaceuticals of Kenilworth, N.J., was approved in 1996. The availability of the two albuterol HFA MDIs offers patients important alternatives to their present albuterol CFC medications.

Since 1978, the use of CFC-propelled aerosol products in this country has been sharply reduced because of increasing evidence that CFCs contribute to the depletion of the Earth's protective ozone layer.

With time, it is expected that these and other CFC-free alternatives will prove to be fully acceptable replacements for the current CFC products, allowing for eventual removal of albuterol CFC MDIs from the market. The removal would occur through a process of public rulemaking, allowing patients, doctors, and others to provide input before the agency takes any actions.

COPYRIGHT 2001 U.S. Government Printing Office
COPYRIGHT 2004 Gale Group

Return to Ventolin
Home Contact Resources Exchange Links ebay